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Abstract
Title: Transnasal Sphenopalatine Ganglion Block: A Novel Solution for Postdural Puncture
Headaches
Background: A 29-year-old female patient presented for treatment of a postdural postural
headache (PDPH) via epidural blood patch (EBP). This patient had a history of chronic
migraines and had undergone epidural anesthesia for labor 6 weeks prior. Despite numerous
conservative treatment attempts, she remained in pain. Eventually an EBP was successfully
performed; although, it could be argued that a transnasal sphenopalatine ganglion block (TSGB)
would have been an appropriate alternative treatment modality.
Purpose: To evaluate the current data regarding TSGB for treatment of PDPH in the obstetric
patient.
Process: A systematic literature review was completed using the University of North Dakota’s
Harley E. French Library databases and textbooks from the Nurse Anesthesia program. Several
limits were placed while searching databases, i.e. CINAHL, PubMed, and the Cochrane Library,
to better pursue the most recent and relevant information. Data was compounded to create
anesthetic recommendations for obstetric patients presenting with PDPHs.
Results: Although case studies discovered on the evidentiary level which specifically apply to the
obstetric population are limited; there are a multitude of randomized controlled studies with
supportive data regarding TSGB for treatment of chronic headaches that can be extrapolated to
infer the importance of future research on treatment for PDPHs.
Implications: This independent project encourages future research into the use of a transnasal
sphenopalatine ganglionic block (TSBG) for treatment of postdural puncture headaches (PDPHs)
for parturients. It is important to determine recommendations for the dosage and type of local
anesthetic that delivers the best pain relief with the least amount of side effects. Given that
parturients are not an easily studied population; it would be prudent to recommend the
development of a website to gather information regarding the events leading up to accidental
dural punctures, postdural puncture headaches and effectiveness and order of treatments prior to
relief. This would allow for a wide spectrum of demographic, patient, technique and provider
variability that could ultimately lead to cementing a logical PDPH treatment process for
parturients.
Keywords: PDPH, EBP, TSGB, obstetrics, accidental dural puncture
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Background
Anesthesia providers continue to discover new ways to implement obstetric anesthetic
methods that keep the parturient and fetus safe. Regional anesthesia is the preferred method of
anesthesia for the majority of anesthesia related obstetric procedures. In 2016, there were
3,945,875 births in the United States of America; of those births, 2,901,486 women underwent
epidural or spinal anesthesia during labor (CDC, 2018). Based on this data, we can extrapolate
that a large portion, 73.5%, of laboring females undergo regional anesthesia for obstetric pain
management.
While regional anesthesia is considered a safe method to facilitate a pleasant childbirth, it
is not without potential complications, such as a postdural puncture headache (PDPH). A PDPH
is a postural headache that occurs when a dural puncture causes a loss of cerebrospinal fluid. The
brain loses its fluid cushion and drops down into the foramen magnum and causes traction on the
meninges, and the associated headache, that is only relieved by laying horizontal.
Accidental dural puncture occurred 1.5% of the time in the obstetric patient population
and of that population more than half of those patients experienced a postdural puncture
headache (Susecon, Austin, & Gabaldon, 2016). Approximately 21,700 women experience a
significant adverse effect secondary to regional anesthesia. This undesirable incident can cloud
the obstetric experience, increase hospital length of stay, decrease patient satisfaction, and
impede the maternal-newborn bonding experience (CDC, 2018).
The gold standard treatment for a PDPH is an epidural blood patch (EBP). While EBPs
are extremely effective, they are considered an invasive treatment and subsequently so, have
higher complications. An alternative, noninvasive option gaining popularity is a transnasal
sphenopalatine ganglion block (TSGB). This independent project examined the benefits of
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incorporating a TSGB into a treatment protocol for PDPH and was developed to answer the
following question: Among parturients who underwent regional anesthesia for labor and
delivery, how does a transnasal sphenopalatine ganglion block compare to an epidural blood
patch in respect to symptom relief from a postdural puncture headache?
Case Report
A 29-year-old 5’2” female weighing 94 kg, BMI 37.8, presented with a PDPH. She was
categorized as an ASA 2, Mallampati I with a thyromental distance of three fingerbreadths, and
full range of motion of the neck. She reported allergies to the influenza vaccine and latex.
Pertinent medical history included asthma and migraines, surgical history of cholecystectomy
and knee surgery with no noted personal or familial anesthetic complications. She was actively
using the following medications: albuterol, oxycodone, baclofen, metronidazole, ibuprofen,
dulera and fluticasone.
This patient experienced a PDPH after undergoing an epidural for a vaginal delivery at an
outside facility. She was a G4 P4 individual who had epidurals in her past deliveries without
complications. She could not say for certain whether or not the epidural had resulted in a dural
tear and leak or “wet tap,” but she did report that the epidural was positional. She returned to the
outside facility post-op day 5 reporting an intractable headache that was postural in nature. She
also reported left-sided sciatic pain and intermittent left leg numbness; the outside facility
completed an MRI which was negative, and they treated her with morphine and intravenous
fluids and sent her home. She reported to this facility post-op day 15 with a bifrontal intractable
headache, postural in nature with photophobia. In addition, she had pain at the lumbar injection
site and the following relevant symptoms: elevated CRP, WBC 11,000, hemoglobin of 13, heart
rate 118, blood pressure 108/72 and temperature 101.6. Blood cultures, urinalysis, repeat MRI,
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CT, and influenza screen were all negative. She was started on Rocephin and vancomycin. Her
tachycardia resolved after 2 liters of fluid. On post-op day 16, a lumbar puncture was completed
(negative) with an opening pressure of 19 cm H20. The hospitalist team treated her headache
with opioids, fluids, and gabapentin. On post-op day 17, they ruled out mastitis and added
caffeine, fioricet, a lidocaine patch, baclofen and steroids to her treatment. On post-op day 20,
she continued treatment with fioricet, oxycodone-acetaminophen, prednisone, baclofen and
motrin; physical and occupational therapies were added at this time because her left leg
weakness had worsened. She was discharged home on post-op day 21 with plans for follow up
appointments and regular physical therapy.
The patient continued with physical therapy with therapists noting increased strength in
the left leg. On post-op day 30 she was treated in the ER for her headache with fluids,
metoclopramide and diphenhydramine; she was referred to the clinic where they stopped the
fioricet, but continued the baclofen, ibuprofen and oxycodone. She was diagnosed with bacterial
vaginosis and started on metrogel on post-op day 36. She saw her primary care physician on
post-op day 38 and underwent battlefield acupuncture (auricular needle placement) which
resulted in slight headache relief but no relief to her back pain. During post-op week 5, she also
sought out alternative therapies and tried acupuncture and massage as well as saw an optometrist.
Neurology saw her on post-op day 39 and recommended a bilateral occipital nerve block. On
post-op day 44 she had an obstetric follow up appointment and then came to the PACU for an
epidural blood patch (this referral was made during a pre-op surgical appointment).
She was interviewed regarding the development and progression of her symptoms,
responses to treatments and goals for her care. Her current symptoms were an intractable
bifrontal headache, which she rated a 9/10 with visual disturbances and nausea. She reported
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minimal relief from the headache via medications and reported that they made her groggy and
nervous about breastfeeding her newborn. The physical interventions of acupuncture, massage,
and physical therapy provided little relief. She reported compliance with drinking fluids and
caffeine throughout the ordeal. She understood that given the increased length of time between
dural puncture and treatment with an epidural blood patch, the treatment was less efficacious. A
transnasal sphenopalatine ganglion block was proposed to the anesthesiologist given that she had
symptoms consistent with both a postdural puncture headache and a chronic headache; he agreed
to try the block if the epidural blood patch was unsuccessful. After receiving 2 mg of IV
midazolam for anxiety, the procedure commenced. 18 mL of sterile autologous blood was
injected into the L2-L3 interspace without incident one space above where her previous puncture
sites were. The patient was immediately laid flat for 1 hour. After the hour, she was sat up and
reported a significant relief in her headache, however, it was not completely gone, but it had
decreased to a tolerable 2/10. The patient returned to the hospital on post-op day 46 for a
scheduled bilateral salpingectomy and inguinal hernia repair, at which time she reported that her
headache had dissipated.
Literature Review
Literature Review Methods
In order to research this topic, I used available databases from the University of North
Dakota’s Harley E. French Library, i.e. CINAHL, PubMed, and Cochrane Library. The
University of North Dakota’s Nurse Anesthesia Program’s relevant textbooks were also perused
for information. CINAHL, the Cumulative Index of Nursing and Allied Health Literature is a
large nursing research database. The PubMed database was developed by the National Library of
Medicine and contains Medline resources. Cochrane library contains highly evidence-based
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systematic reviews. The following keywords were identified from the PICO question:
sphenopalatine ganglion block, epidural blood patch, postdural puncture headache, obstetrics,
and parturients.
A search of “postdural puncture headache” in CINAHL with the limiting factors of
published after 2007, English language, and peer-reviewed yielded 31 results, 4 of which were
especially informative (Kooten, Oedit, Bakker, & Dippel, 2008; Bezov, Lipton, & Ashina, 2010;
Bezov, Ashina, & Lipton, 2010; Stein, Cohen, Mohiuddin, Dombrovskiy, & Lowenwirt, 2014).
Searching “sphenopalatine ganglion block” on CINAHL with the same limits produced 14
articles, 2 of which were also informative (Kent & Mehaffey, 2015; Robbins, Robertson, Kaplan,
Ailani, Charleston, Kuruvilla, Blumenfeld et al, 2016). “Epidural blood patch” yielded 99
articles with the same restrictions from CINAHL. A combination of “epidural blood patch” and
“obstetrics” generated 5 articles, 1 of these was relevant and not previously found (Susecun,
Austin, & Gabaldon, 2016). All relevant articles were read and reference lists were investigated
for further sources.
Similar limits were used in the PubMed database: full text, English language, less than 10
years old, and human species. A search of “postdural puncture headache” yielded 403 results.
When combined with “sphenopalatine ganglion block,” it resulted in 7, 3 of which were not
discovered in CINAHL, and 1 of which was relevant (Nair, 2017). “Epidural blood patch”
yielded 470 results, but combined with “obstetrics” formed 47 results, 1 of which was
specifically relevant (Harrington & Schmitt, 2009). “Sphenopalatine ganglion block” yielded 61
results, 2 of which were especially relevant and not previously discovered (Schaffer, Hunger,
Ball & Weaver, 2015; Robbins et al, 2016; Mojica, Mo & Ng, 2017).
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A search of the online Cochrane Library database with similar limits, 2007-2017 and
English, yielded 13 results for “sphenopalatine ganglion block,” none of which are relevant.
“Epidural blood patch” found 2 systematic reviews, 1 of which detailed medication therapy for
PDPH (Ona, Osorio, & Cosp, 2015). Other search attempts within clinical trials of “obstetric
postdural puncture headache” generated 12 results, none of which were new or relevant.
Ultimately, 2 textbooks and 18 relevant articles were discovered in the literature review. Articles
include systematic reviews, clinical trials, and case reports.
Discussion
Pathophysiology of PDPH
A PDPH is an adverse risk of undergoing regional anesthesia for labor and delivery. A
PDPH can occur from any incident in which the dural membrane is disrupted, i.e. a lumbar
puncture, myelogram, or central regional anesthesia. It can result from either spinal or epidural
regional attempts; however, it is more common in epidural anesthesia. It is often the result of a
“wet tap,” or an epidural needle going past the epidural space and into the dural space; the larger
needle in the dural space allows for rapid outflow of cerebrospinal fluid (CSF).
There are two theories regarding the mechanism of injury revolving around a PDPH. The
first is that when an accidental dural tear occurs, there is a loss in the CSF and the buoyant
environment that usually supports the brain. This disruption in CSF flow, pressure and volume
causes a “downward pull on pain-sensitive structures in the upright position… tension placed on
meninges and blood vessels containing stretch pain sensors” (Baysinger, 2014, p. 19). This
pressure-volume mismatch can only be relieved by the patient lying flat, as this relieves the
downward pressure on the meninges and allows the brain to “float” in the CSF again (Sachs &
Smiley, 2014). An alternative theory centers on the Monro-Kellie hypothesis: the sum of the
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brain, CSF and blood volume is constant, an increase in one compartment must cause a decrease
in one or two of the other compartments. When the body experiences a loss of CSF volume it
responds by increasing the blood volume. To compensate for the increased blood volume, the
parasympathetic nervous system is reflexively stimulated to dilate the intracranial and spinous
vessels causing venous engorgement (Syed, Mirza, Pabaney, & Hassan, 2012). This pressurevolume mismatch also causes the postural headache. Current conservative treatment for PDPH
include bedrest, fluids, abdominal binders, caffeine, analgesics, and time. Most PDPH are selflimiting and will resolve in 5-14 days.
Signs and Symptoms of PDPH
Postdural puncture headaches often present 24-48 hours after a dural tap. It is usually
bifrontal in nature, described as aching or throbbing, and can radiate to the occipital portion of
the cranium. It is postural in nature, it is aggravated by a vertical position and relieved by lying
flat. The patient may also experience nausea, vomiting, visual changes, tinnitus, hearing changes,
cranial nerve palsies, vertigo and neck pain (Nagelhout & Plaus, 2014; Susecon, Austin,
Gabaldon, 2016). The diplopia and tinnitus are caused by traction on the cranial nerves
(Butterworth, Mackey, & Wasnick, 2013).
Differential Diagnosis of PDPH
It is imperative to correctly identify and diagnose the headache as a postdural puncture
headache (Sachs & Smiley, 2014; Nagelhout & Plaus, 2014). Improper diagnosis and subsequent
treatment has the potential for neurological sequelae, especially in the parturient population. It is
important that anesthesia providers assess the patient for signs and symptoms that do not align
with a PDPH and could be indicative of a graver diagnosis.
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Arachnoiditis and meningitis are infectious complications characterized by fever, back
pain, and neurological symptoms; classic meningitis signs include high fever, nuchal rigidity,
and a severe non-postural headache. Epidural abscesses are also an infectious complication and
include fever and progressively deteriorating symptoms of back pain, nerve root pain, radicular
pain, motor deficits, sensory deficits, sphincter dysfunction, paraplegia, and paralysis
(Butterworth, Mackey, & Wasnick, 2013).
Spinal and epidural hematomas occur when there is trauma to an epidural vein that causes
bleeding and subsequent compression to the neural tissue. This compression can negatively
influence spinal cord perfusion and cause ensuing neurologic symptoms based on location but
often include “sharp back and leg pain with a motor weakness and/or sphincter dysfunction”
(Butterworth, Mackey, & Wasnick, 2013, p. 970).
A tension headache is band-like in nature with neck and shoulder pain, it lasts hours to
days, and it does not worsen with position and activity. Pregnancy is known to decrease
migraines due to the hormonal changes; however, many women suffer from a reappearance of
migraines in the postpartum period. Migraines are often pulsating focal headaches with vision
changes and nausea lasting several hours to days. Other potential critical etiologies that need to
be ruled out with imaging include subarachnoid hemorrhage, cerebral tumor, and strokes
(Sabharwal & Stocks, 2011).
Prevalence and Risk Factors of PDPH
The occurrence of PDPHs varies significantly based on the source: 0.2-24% (Nagelhout
& Plaus, 2014), 2-70% (Kent & Mehaffey, 2015), 3-50% (Butterworth, Mackey, & Wasnick,
2013). The disparity in incidence is highly attributable to the presence or absence of risk factors.
The prevalence of PDPHs are principally inversely proportional to the needle size (Kent &
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Mehaffey, 2015). Anesthesia providers should take all precautions to minimize the risk factors
associated with PDPHs. Factors that increase the risk of PDPHs which are heavily influenced by
the provider include previous experience, using a large epidural needle, using a cutting needle
rather than a pencil-point needle, placing the bevel perpendicular to the longitudinal spine, and
attempting multiple insertions. Patient risk factors include young, female, low-normal weight,
abnormal anatomy, pregnant, and a previous history of postdural puncture headache (Nagelhout
& Plaus, 2014; Kokki, Sjovall, Keinanen, & Kokki, 2013; Baysinger, 2014).
Non-Invasive Treatment Options for PDPH
Conservative medical treatment includes bedrest, oral and intravenous hydration,
caffeine, gabapentin, hydrocortisone, theophylline, sumatriptan, pregabalin, cosyntropin, and
adrenocorticotropin hormone. There is a significant decrease in PDPH persistence with
intravenous caffeine. There is a significant decrease in pain scores with gabapentin,
hydrocortisone, and theophylline. There is no significant change in PDPH persistence or pain
with cosyntropin, pregabalin, sumatriptan, and adrenocorticotropic hormone (Ona, Osorio, &
Bonfill, 2015). Bedrest will alleviate the symptoms, but it will not hasten the recovery process
(Sachs & Smiley, 2014). IV hydration will not improve CSF production, but dehydration will
inhibit CSF production and prolong PDPH symptoms (Nagelhout & Plaus, 2014). Some
anesthesia providers have reported success with threading an intrathecal catheter for 24 hours
when confronted with an accidental dural puncture, as this is thought to trigger the inflammatory
process and speed the closure of the dural puncture (Baysinger, Pope, Lockhart, & Mercaldo,
2011). Despite advancements regarding non-invasive treatment options, studies concur that the
gold standard of treatment remains an epidural blood patch.
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Invasive Treatment Options for PDPH
Epidural Blood Patch
An epidural blood patch (EBP) is the definitive, although invasive, treatment modality for
PDPH. An EBP is a sterile procedure. A patient’s arm and back are draped in the appropriate
aseptic manner. Two providers are required, one to draw the autologous blood from a peripheral
vein and another to achieve epidural access. Once access to the epidural space at, or below the
level of the initial puncture point is confirmed with loss of resistance by the first provider, the
second provider obtains 20-30 milliliters of autologous blood and, while maintaining sterility,
hands it to the second provider. This autologous blood is infused into the epidural space until the
patient reports pressure, usually around 15-20 milliliters. The needle is withdrawn and the patient
is placed supine for 30-60 minutes. EBP aids in clot formation and provides mechanical pressure
against the dural puncture point, increasing CSF pressure, which relieves meningeal tension
(Butterworth, Mackey, & Wasnick, 2013; Nagelhout & Plaus, 2014).
EBP Physiology
Researchers believe that an EBP relieves a PDPH by two mechanisms: it immediately
provides mechanical pressure against the dural puncture point, increasing CSF pressure, which
relieves the tension on the meninges and increases intracranial pressure (Butterworth, Mackey, &
Wasnick, 2013; Baysinger, 2014) and it speeds the formation of a clot as the blood adheres to the
dura and seals the hole in the meninges (Sachs & Smiley, 2014; Baysinger, 2014). Given that the
exact mechanism of injury remains to be fortified; it is easy to see why treatment procedures
vary institution to institution.
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EBP success rate/efficacy
EBP is a highly successful treatment modality for PDPHs with a 90-95% cure rate. If it is
not successful initially, a second EBP repeated 24 hours later has a 90% cure rate. Timing of
EBP greatly influences the efficacy. EBP are most efficacious if performed 48 hours after the
dural puncture (Kokki, Sjovall, Keinanen, & Kokki, 2013, p.307).
EBP Side-effects & Contraindications
Contraindications to EBPs include systemic infection, fever, current neurologic sequelae,
anticoagulation/coagulopathy abnormalities, and patient refusal or lack of cooperation
(Nagelhout & Plaus, 2014; Tubben & Jain, 2018). Potential side effects are the same as those
that exist when performing an epidural anesthetic: direct spinal cord injury, accidental dural
puncture, cerebrospinal fluid leakage, epidural abscess, epidural hematoma, vascular injection,
infection at the site, meningitis, arachnoiditis, compressive radiculopathy, cauda equina
syndrome, and unintentional subarachnoid injection (Pino et al, 2014; So, Park, Lee, Kim, Lee,
& Kim, 2016, p. E1117).
EBP Variation
Common practice among anesthesia providers is to administer 15-30 ml autologous blood
as tolerated by the patient until the patient experiences intolerable pain. The “ideal blood volume
to administer during an EBP remains unknown” (Booth, Pan, Thomas, Harris, & D’Angelo,
2017, p. 16), there also is no known amount of epidural blood to administer in repeat epidural
blood patches. Epidural saline injection is thought to temporarily equalize the pressure between
the epidural and subarachnoid spaces and allow fibrin to seal the dural hole (Suescun, Austin,
Gabaldon, 2016, p.20). However, saline does not hasten the inflammatory response, and the
increase in pressure that causes symptom relief is transient (Baysinger, 2014). Boonmak &
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Boonmak (2010) found no statistically significant results when patients were injected with
epidural or intrathecal saline boluses or infusions for treatment of PDPH.
The level at which the epidural blood patch is administered also varies between
practitioners and facilities. Many anesthesia providers perform an EBP at the same or one level
below the initial puncture point. Given that scanning has shown that blood moves “cephalad and
caudally after injection, passes into the anterior epidural space, and passes through the
intervertebral foramina into the paravertebral space… the thecal sac is compressed by blood with
presumed CSF dislocation cephalad” one can appreciate that the level of injection may not have
a significant effect but it best completed at or below the initial site (Baysinger, 2014, p. 31). No
studies were found comparing level of injection with success rate of EBP.
EBP Prophylaxis
In response to prophylactic treatment for PDPH, i.e. epidural injections of saline,
intrathecal injections of saline, or prophylactic blood patches; it appears the literature does not
support these interventions as the potential risks outweigh the benefits (Sachs & Smiley, 2015;
Susecon, Austin, & Gabaldon, 2016). Gaiser (2013) found that prophylactic EBP was not needed
40% of the time, as it did not affect incidence of severity of PDPH or the need for an EBP. This
author agrees that introducing anything near the spinal cord prior to necessity is greatly
countered by the risk of neuronal tissue damage. Anesthesia providers should take measures to
decrease risk factors associated with accidental dural puncture: needle type, needle size, bevel
direction, loss of resistance technique, provider skill, and less than ideal procedural
considerations.
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Transnasal Sphenopalatine Ganglion Block
Anatomy
The sphenopalatine ganglion is a cone shaped ganglion that is suspended from the
maxillary nerve and then dissipates into the nasopalatine nerve, greater palatine nerve, lesser
palatine nerve, lateral nasal branches, and the pharyngeal branch of the maxillary nerve, as well
as the orbital branches (Robbins et al, 2016). The sphenopalatine ganglion is an “extracranial
neural structure located in the pterygopalatine fossa that has both sympathetic and
parasympathetic components as well as somatic sensory roots” (Kent & Mehaffey, 2015, p.
1714e1); and when activated, it causes the release of acetylcholine, peptides and nitric oxide
which subsequently causes inflammation and triggering of trigeminal nociceptors (Robbins et al,
2016).
Physiology
The transnasal sphenopalatine ganglion block (TSGB) was developed by Dr. Sluder in
1908 for treatment of headaches and it continues to be an effective methodology for various
chronic headache scenarios, trigeminal neuralgia, and ENT surgeries (Robbins et al, 2016;
Schaffer, Hunter, Ball & Weaver, 2015). The sphenopalatine ganglion block inhibits the
parasympathetic stimulation so meningeal and cerebral vessels can regulate without excess
parasympathetic vasodilation and the headache dissipates (Kent & Mehaffey, 2015, p. 1714e1), it
also blocks the activation of meningeal nociceptor fibers (Channabasappa, Manjunath,
Bommalingappa, Ramachandra & Banuprakash, 2017). TSBG is a newly proposed alternative
method to treatment of postdural puncture headaches (PDPH).
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Procedure
There are several ways to administer a TSGB with varied amounts of technical expertise
required, “local application of the drug, administering it using a dropper, spraying, and injecting
the drug under direct visualization” (Robbins et al, 2016, p. 245). Direct drop administration
usually requires less setting time (30-60 seconds per nare). Kent & Mehaffey (2016) performed
the TSGB on obstetric patients in the following manner: patient placed supine with neck
extended, intranasal phenylephrine spray administered, hollow cue-tips saturated with 2%
viscous lidocaine were placed into each nare until reaching the posterior nasopharynx and remain
there for 10 minutes; the applicators were removed, re-saturated with lidocaine, and the
procedure was repeated. The patient was then sat up and evaluated. Several applicators,
i.e.Tx360, SphenoCath, and Allevio, have been developed to improve proper placement and can
be combined with fluoroscopy to increase success of the block and decrease the amount of local
anesthetic needed to saturate the sphenopalatine ganglion. After a rest period in the supine
position, the patient is sat up and pain is evaluated, if at that time there was no relief in
symptoms it would be appropriate to discuss other interventions and/or perform the gold
standard epidural blood patch.
Various amounts and concentrations of local anesthetics have been utilized for TSGB.
The diversity in medication administration is likely due to the differences in method of
administration, the acuteness or chronicity of the headache, and how soon after onset the block
was performed. Providers have used 1 puff of 10% lidocaine, 6% lidocaine drops, 10% cocaine
drops, 4% lidocaine drops, 0.5 ml 0.4% lidocaine, 1 ml 4% lidocaine, 2% intranasal viscous
lidocaine, 20% lidocaine dipped cotton applicators, 1-2 ml 2% lidocaine, 0.5 ml 0.5%
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ropivacaine, and 0.3 ml of 0.5% bupivacaine (Robbins et al, 2016). The previously listed
assortment encourages further research into the best medication and dose for TSGB.
Efficacy
Transnasal sphenopalatine ganglion blocks have proven to be successful in treatment and
prevention of chronic headaches with some patients reporting relief from cluster headaches for
anywhere from 1-24 months in duration (Robbins et al, 2016). A literature review performed by
Mojica, Mo & Ng (2017) found a variety of researchers’ success with TSGB for treatment of
chronic headaches with a majority of patients reporting a 65-85% reduction in the intensity of
their headache. TSGB is a promising, easily performed, low risk, alternative treatment for PDPH.
Although several studies exist for TSGB for headache patients, very few exist for the obstetric
population. Small limited studies show potential, i.e. Cohen, Sakr, Katyal, & Chopra (2009) and
Kent & Mehaffey (2016).
Kent and Mehaffey (2016) offered an EBP or a TSGB to 3 obstetric patients who
suffered an accidental dural puncture (ADP) and subsequent PDPH. The first patient had an ADP
and successive intrathecal catheter placement. After catheter removal she developed a PDPH;
despite medical management and analgesics at home, she returned to the ER at 5 days postpuncture with a 9/10 headache. This was relieved with a TSGB to 0/10 and remained 0/10 at 24
and 48 hours. Patient 2 had a PDPH develop shortly after an uneventful labor epidural catheter
was removed, she received a TSGB 4 days post-puncture for an 8/10 headache that was relieved
with a TSGB to 0/10, at 24 hours it was 3/10 and at 48 hours if was 2/10 and tolerable. The third
patient had an accidental dural puncture and consequential intrathecal catheter placement. When
the catheter was removed, she developed a PDPH, she went home on oral analgesics, returned 4
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days post-puncture for an EBP which relieved pain for only 2 days; she then she returned 9 days
post-puncture for a TSGB which provided immediate relief and 0/10 pain at 24 and 48 hours.
Cohen, Sakr, Katyal, & Chopra (2009) found that 11/13 obstetric patients reported relief
after TSGB. It is their practice to offer a TSGB with 4% lignocaine prior to an EBP. They also
offer TSGBs daily or provide instructions and supplies for the patient to complete a TSGB at
home for 1 week. They do report an “unpredictable” success rate, with some patients reporting
immediate and complete relief of pain while others reporting transient relief and a few that
require an EBP for relief of symptoms. Cohen, Ramos, Grubb, Mellender, Mohiuddin &
Chiricolo (2014) reported a 69% success rate in 32 obstetric patients with PDPH. They utilized
cue-tips saturated with 5% water soluble lidocaine ointment into each nare for 10 minutes.
PDPH Treatment Comparison
Although EBPs are over 90% effective, they are invasive (Nagelhout & Plaus, 2014).
TSGB should be studied further as an alternative noninvasive method to EBPs for treatment of
PDPHs. It is a noninvasive, relatively successful block that has a mild side effect profile of only
bleeding, discomfort, mouth numbness, dissatisfying taste, and a failed block; whereas, an EBP
has a side effect profile including infection, dural puncture, spinal hematoma, neurological
complications, and patient discomfort. TSGB is also less expensive and requires less skill to
perform than an epidural blood patch. EBPs have several relative and absolute contraindications,
whereas TSGB have only patient refusal and basilar skull fractures as contraindications. Overall,
TSGB deserves to be investigated as an alternative approach to an EBP for treatment of PDPHs.
Comparison of Case with Evidence
The patient demonstrated some symptoms consistent with a PDPH; however, the
timeframe was abnormal. She was 6 weeks post-epidural puncture for labor and 4 weeks post
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diagnostic lumbar puncture. The anesthesia provider hypothesized that the dural tear had
possibly formed a fibrin scar that encircled the dural orifice and was allowing a continuous dural
leak.
The abnormal timeframe was problematic in determining the origin of the headache. She
also had a history of migraines but reported that the symptomology of her migraines was vastly
different then her current symptoms. The patient’s symptom profile did not fully correlate with
only a PDPH. Differential diagnoses and potential etiologies of the headache had been
previously addressed through imaging and labs and various specialties (neurology, physical
therapy, and massage therapy). It would have been beneficial to gain access to the outside
facility’s records regarding the labor epidural to assess for any immediate procedural
complications or presence of a “wet tap” or dural leak.
Given the ambiguity of the symptoms and haziness regarding the labor epidural, although
the EBP was successful, one can argue that a TSGB would have been a more appropriate
treatment choice. It is a noninvasive, easy block with minimal side effects and a documented
treatment modality for both a PDPH and a chronic headache. The patient was visibly anxious and
afraid of needles. Taking the previous information into consideration and that the efficacy of a
PDPH decreases with time from the dural puncture incident, perhaps a TSGB should have been
attempted first.
Anesthesia Implications
Although case studies discovered on the evidentiary level which specifically apply to this
case study are few, there are a multitude of articles with supportive data regarding TSGB for
treatment of chronic headaches that can be extrapolated to infer the importance of future research
on treatment for PDPHs. Anesthesia providers should anticipate the development of a PDPH
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treatment algorithm that includes conservative medical management (hydration, bedrest,
caffeine, analgesics) and aggressive procedural management (TSGB and EBP) for parturients.
The literature review conducted for this independent project encourages future research
into the use of a TSBG for treatment of PDPHs for parturients. It is important to determine
recommendations for the dosage and type of local anesthetic that delivers the best pain relief
with the least amount of side effects. Given that parturients are not an easily studied population;
it would be prudent to recommend the development of a website to gather information regarding
the events leading up to accidental dural punctures, postdural puncture headaches, and
effectiveness and order of treatments prior to relief. This would allow for a wide spectrum of
demographic, patient, technique and provider variability that could ultimately lead to cementing
a logical treatment process for parturients.
Conclusion
Parturients are a special population within the healthcare realm whose satisfaction with
anesthesia services is highly influential on patient satisfaction scores and subsequently hospital
length of stay, healthcare costs, and readmittance. It is imperative that anesthesia providers have
a multitude of treatment modalities within their arsenal to combat adverse effects of regional
anesthesia for labor. Nevertheless, experiments regarding this population are often small and
retrospective for apparent reasons. Further research is required to develop the best TSGB
technique, but this independent project supports the addition of TSGB into a treatment algorithm
for PDPH.
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